Sharon Hemond Hrynkow - Net Worth and Insider Trading
Sharon Hemond Hrynkow Net Worth
The estimated net worth of Sharon Hemond Hrynkow is at least $18,466 dollars as of 2024-12-01. Sharon Hemond Hrynkow is the Chief Scientific Officer of Cyclo Therapeutics Inc and owns about 19,350 shares of Cyclo Therapeutics Inc (CYTH) stock worth over $12,432. Sharon Hemond Hrynkow is also the Director of Forward Industries Inc and owns about 1,486 shares of Forward Industries Inc (FORD) stock worth over $6,033. Details can be seen in Sharon Hemond Hrynkow's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Sharon Hemond Hrynkow has not made any transactions after 2022-12-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Sharon Hemond Hrynkow
Sharon Hemond Hrynkow Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Sharon Hemond Hrynkow owns 2 companies in total, including Cyclo Therapeutics Inc (CYTH) , and Forward Industries Inc (FORD) .
Click here to see the complete history of Sharon Hemond Hrynkow’s form 4 insider trades.
Insider Ownership Summary of Sharon Hemond Hrynkow
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CYTH | Cyclo Therapeutics Inc | 2021-12-02 | SVP for Medical Affairs |
| FORD | Forward Industries Inc | 2022-12-20 | director |
Sharon Hemond Hrynkow Latest Holdings Summary
Sharon Hemond Hrynkow currently owns a total of 2 stocks. Among these stocks, Sharon Hemond Hrynkow owns 19,350 shares of Cyclo Therapeutics Inc (CYTH) as of December 2, 2021, with a value of $12,432 and a weighting of 67.33%. Sharon Hemond Hrynkow also owns 1,486 shares of Forward Industries Inc (FORD) as of December 20, 2022, with a value of $6,033 and a weighting of 32.67%.
Latest Holdings of Sharon Hemond Hrynkow
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CYTH | Cyclo Therapeutics Inc | 2021-12-02 | 19,350 | 0.64 | 12,432 |
| FORD | Forward Industries Inc | 2022-12-20 | 1,486 | 4.06 | 6,033 |
Holding Weightings of Sharon Hemond Hrynkow
Sharon Hemond Hrynkow Form 4 Trading Tracker
According to the SEC Form 4 filings, Sharon Hemond Hrynkow has made a total of 2 transactions in Cyclo Therapeutics Inc (CYTH) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Cyclo Therapeutics Inc is the acquisition of 1,000 shares on December 2, 2021, which cost Sharon Hemond Hrynkow around $4,980.
According to the SEC Form 4 filings, Sharon Hemond Hrynkow has made a total of 1 transactions in Forward Industries Inc (FORD) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Forward Industries Inc is the acquisition of 986 shares on December 20, 2022, which cost Sharon Hemond Hrynkow around $11,235.
Insider Trading History of Sharon Hemond Hrynkow
- 1
Sharon Hemond Hrynkow Trading Performance
GuruFocus tracks the stock performance after each of Sharon Hemond Hrynkow's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Sharon Hemond Hrynkow is -7.51%. GuruFocus also compares Sharon Hemond Hrynkow's trading performance to market benchmark return within the same time period. The performance of stocks bought by Sharon Hemond Hrynkow within 3 months outperforms 1 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Sharon Hemond Hrynkow's insider trading performs compared to the benchmark.
Performance of Sharon Hemond Hrynkow
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -7.1 | | | | | |
| Relative Return to S&P 500(%) | -9.38 | | | | | |
Sharon Hemond Hrynkow Ownership Network
Sharon Hemond Hrynkow Owned Company Details
What does Cyclo Therapeutics Inc do?
Who are the key executives at Cyclo Therapeutics Inc?
Sharon Hemond Hrynkow is the SVP for Medical Affairs of Cyclo Therapeutics Inc. Other key executives at Cyclo Therapeutics Inc include 10 percent owner Rafael Holdings, Inc. , director & Chief Executive Officer Jeffrey Tate , and Chief Medical Officer Lise Lund Kjems .
Cyclo Therapeutics Inc (CYTH) Insider Trades Summary
Over the past 18 months, Sharon Hemond Hrynkow made no insider transaction in Cyclo Therapeutics Inc (CYTH). Other recent insider transactions involving Cyclo Therapeutics Inc (CYTH) include a net purchase of 4,000,000 shares made by Rafael Holdings, Inc. ,
In summary, during the past 3 months, insiders sold 0 shares of Cyclo Therapeutics Inc (CYTH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cyclo Therapeutics Inc (CYTH) were sold and 4,000,000 shares were bought by its insiders, resulting in a net purchase of 4,000,000 shares.
Cyclo Therapeutics Inc (CYTH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cyclo Therapeutics Inc Insider Transactions
Sharon Hemond Hrynkow Mailing Address
Above is the net worth, insider trading, and ownership report for Sharon Hemond Hrynkow. You might contact Sharon Hemond Hrynkow via mailing address: 4816 King Solomon Drive, Annadale Va 22003.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
